Keros Therapeutics, Inc. (KROS) Gross margin
Keros Therapeutics, Inc. (KROS) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to KROSSource: SEC XBRL filings · For reference only · Not investment advice